Literature DB >> 9374203

Proline-induced inhibition of glutamate release in hippocampal area CA1.

S M Cohen1, J V Nadler.   

Abstract

Concentrations of proline typical of human CSF have been shown to potentiate transmission at Schaffer collateral-commissural synapses on CA1 pyramidal cells of the rat hippocampus. This study tested the hypothesis that proline enhances excitatory synaptic transmission by increasing glutamate release. Two concentrations of proline were used: a concentration typical of normal human CSF (3 microM) and a concentration typical of CSF in persons with the genetic disorder hyperprolinemia type II (30 microM). Continuous exposure of hippocampal slices to either concentration of proline potentiated Schaffer collateral-commissural synaptic transmission. Proline shifted the plot of field EPSP slope against fiber volley amplitude upward. Contrary to the original hypothesis, neither concentration of proline reduced paired-pulse facilitation; 30 microM proline enhanced paired-pulse facilitation, whereas 3 microM proline had no effect. In line with its enhancement of paired-pulse facilitation, 30 microM proline reduced both the K+-evoked release of glutamate and aspartate from CA1 slices and the release of glutamate and aspartate from CA1 synaptosomes evoked by 4-aminopyridine. These results suggest that the proline-induced potentiation of Schaffer collateral-commissural synaptic transmission probably involves a postsynaptic, rather than a presynaptic, mechanism. Concentrations of proline normally found in human CSF little affect glutamate release. However, proline-induced inhibition of glutamate release may contribute to the neuropsychiatric disorders associated with hyperprolinemia type II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374203     DOI: 10.1016/s0006-8993(97)00721-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

Review 1.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

3.  Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.

Authors:  Catherine L Clelland; Laura L Read; Amanda N Baraldi; Corinne P Bart; Carrie A Pappas; Laura J Panek; Robert H Nadrich; James D Clelland
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

4.  Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.

Authors:  James D Clelland; Laura L Read; Valérie Drouet; Angela Kaon; Alexandra Kelly; Karen E Duff; Robert H Nadrich; Amit Rajparia; Catherine L Clelland
Journal:  Schizophr Res       Date:  2014-04-29       Impact factor: 4.939

Review 5.  Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate.

Authors:  A J Robison; Katharine N Thakkar; Vaibhav A Diwadkar
Journal:  Biol Psychiatry       Date:  2019-10-03       Impact factor: 13.382

Review 6.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

7.  Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.

Authors:  Jacob A S Vorstman; Bruce I Turetsky; Monique E J Sijmens-Morcus; Monique G de Sain; Bert Dorland; Mirjam Sprong; Eric F Rappaport; Frits A Beemer; Beverly S Emanuel; René S Kahn; Herman van Engeland; Chantal Kemner
Journal:  Neuropsychopharmacology       Date:  2008-09-03       Impact factor: 7.853

8.  Networks of attention in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Sarah Daniels; Maude Blundell; Kwame Anyane-Yeboa; Maria Karayiorgou
Journal:  Dev Neuropsychol       Date:  2004       Impact factor: 2.253

9.  Effect of proline on creatine kinase activity in rat brain.

Authors:  Adriana Kessler; Elisa Costabeber; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

10.  Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.

Authors:  Fabiana da Silva Alves; Erik Boot; Nicole Schmitz; Aart Nederveen; Jacob Vorstman; Christina Lavini; Petra J Pouwels; Petra Pouwels; Lieuwe de Haan; Don Linszen; Therese van Amelsvoort
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.